Follow
Jonathan Gubbay
Jonathan Gubbay
BC Children's Hospital and Women's Hospital; BC Centre for Disease Control
Verified email at cw.bc.ca
Title
Cited by
Cited by
Year
Diagnosing COVID-19: the disease and tools for detection
B Udugama, P Kadhiresan, HN Kozlowski, A Malekjahani, M Osborne, ...
ACS nano 14 (4), 3822-3835, 2020
18222020
Acute myocardial infarction after laboratory-confirmed influenza infection
JC Kwong, KL Schwartz, MA Campitelli, H Chung, NS Crowcroft, ...
New England Journal of Medicine 378 (4), 345-353, 2018
12162018
Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses
DM Skowronski, NZ Janjua, G De Serres, S Sabaiduc, A Eshaghi, ...
PloS one 9 (3), e92153, 2014
4722014
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
S Nasreen, H Chung, S He, KA Brown, JB Gubbay, SA Buchan, DB Fell, ...
Nature microbiology 7 (3), 379-385, 2022
4112022
Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication
AR Eshaghi, VR Duvvuri, R Lai, JT Nadarajah, A Li, SN Patel, DE Low, ...
PloS one 7 (3), e32807, 2012
3582012
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
H Chung, S He, S Nasreen, ME Sundaram, SA Buchan, SE Wilson, ...
bmj 374, 2021
3172021
Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes
SA Buchan, H Chung, KA Brown, PC Austin, DB Fell, JB Gubbay, ...
JAMA network open 5 (9), e2232760-e2232760, 2022
2822022
Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide
S Isabel, L Graña-Miraglia, JM Gutierrez, C Bundalovic-Torma, HE Groves, ...
Scientific reports 10 (1), 14031, 2020
2272020
A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season
DM Skowronski, C Chambers, S Sabaiduc, G De Serres, AL Winter, ...
Clinical Infectious Diseases 63 (1), 21-32, 2016
2112016
The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study
HE Groves, PP Piché-Renaud, A Peci, DS Farrar, S Buckrell, C Bancej, ...
The Lancet Regional Health–Americas 1, 2021
1822021
Diagnosis and management of first case of COVID-19 in Canada: lessons applied from SARS-CoV-1
X Marchand-Senécal, R Kozak, S Mubareka, N Salt, JB Gubbay, ...
Clinical Infectious Diseases 71 (16), 2207-2210, 2020
1612020
Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A (H3N2) epidemics in Canada, 2010–2011 to 2014–2015
DM Skowronski, C Chambers, G De Serres, S Sabaiduc, AL Winter, ...
The Journal of infectious diseases 215 (7), 1059-1099, 2017
1562017
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
DM Skowronski, NZ Janjua, G De Serres, TS Hottes, JA Dickinson, ...
Bmj 342, 2011
1312011
Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics
VR Duvvuri, A Granados, P Rosenfeld, J Bahl, A Eshaghi, JB Gubbay
Scientific reports 5 (1), 14268, 2015
1302015
Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem
CA Thomson, Y Wang, L Jackson, M Olson, W Wang, S Diederich, ...
Frontiers in immunology 3, 24101, 2012
1272012
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories
JJ LeBlanc, JB Gubbay, Y Li, R Needle, SR Arneson, D Marcino, ...
Journal of Clinical Virology 128, 104433, 2020
1262020
Interim estimates of 2014/15 vaccine effectiveness against influenza A (H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015
DM Skowronski, C Chambers, S Sabaiduc, G De Serres, JA Dickinson, ...
Eurosurveillance 20 (4), 21022, 2015
1252015
Influenza A/subtype and B/lineage effectiveness estimates for the 2011–2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine
DM Skowronski, NZ Janjua, S Sabaiduc, G De Serres, AL Winter, ...
The Journal of infectious diseases 210 (1), 126-137, 2014
1252014
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season
DM Skowronski, NZ Janjua, G De Serres, AL Winter, JA Dickinson, ...
Clinical infectious diseases 55 (3), 332-342, 2012
1252012
Older age and a reduced likelihood of 2009 H1N1 virus infection
DN Fisman, R Savage, J Gubbay, C Achonu, H Akwar, DJ Farrell, ...
New England Journal of Medicine 361 (20), 2000-2001, 2009
1222009
The system can't perform the operation now. Try again later.
Articles 1–20